© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent


Two big infrastructure deals with private capital providers are fuelling hopes of a sustained M&A rebound in Germany
SMG’s drop below offer price sends mixed signals
SMG pares back gains after year’s largest IPO, Verisure to follow
Italy’s top independent investment bank must try to survive inside Monte dei Paschi
More articles/Ad

More articles/Ad

More articles

  • Equity investors have maintained a focus on gaining exposure to tech stocks so far this year in the primary market, dispelling fears that high-growth digital companies might lose out to cyclical, value stocks that might benefit from the reopening of economies from the Covid-19 pandemic.
  • German stocks have continued to be among the best performing in Europe in 2021, fuelling momentum in the country’s equity capital markets.
  • Auction Technologies Group (ATG), the UK technology company that runs online auctions and produces proprietary software for online auctions, has begun investor education for its IPO on the London Stock Exchange and has secured cornerstone orders for the deal.
  • HH&L Acquisition Corp has bagged $360m after increasing the size of its New York Stock Exchange IPO, in yet another sign that Asia-focused blank cheque companies are surging in popularity.
  • Brookfield Asset Management has pulled off India’s third ever real estate investment trust IPO, raising Rp38bn ($521.7m) as strong demand covered the deal multiple times over.
  • Huge demand for exposure to biotech companies among US equity investors is continuing to drive UK firms to list on the other side of the Atlantic through an IPO on the Nasdaq. On Thursday, Immunocore, a late-stage biotech firm focused on T-cell technology, priced an enlarged offering on the exchange and, on Friday, UK healthcare investor Syncona announced it was exploring a US IPO for one of its portfolio companies.